| Peri-Implant Marginal Bone Loss And Implant Stability In Maxillary Implant Overdenture When Using Osseodensification Versus Conventional Drills: A Randomized Clinical Trial (NCT05559632) | Cairo University | 2022-11-01 |
| A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002) (NCT05579132) | MSD R&D (China) Co., Ltd. | 2022-11-01 |
| The Effectiveness and Efficacy of the Combination of the Integrated Psychological Therapy and Metacognitive Training. (NCT05623228) | Rakitzi, Stavroula | 2022-11-01 |
| Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer (NCT05747313) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-11-01 |
| Combination of Haloperidol and Magnesium for Delirium Prevention in Critically Ill Elderly (NCT06168773) | Ain Shams University | 2022-11-01 |
| Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy (NCT05111860) | Shanghai Minimally Invasive Surgery Center | 2022-11-01 |
| Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency (NCT05829187) | Syamsudin Abdillah,Ph.D, Pharm D | 2022-11-01 |
| Colchicine and Inflammation in Hemodialysis Patients (NCT05677555) | Assaf-Harofeh Medical Center | 2022-11-01 |
| Efficacy and Safety of Caldonirimab Plus Nimotuzumab for Recurrent or Metastatic Cervical Cancer (NCT05606263) | Xi'an Jiaotong University | 2022-11-01 |
| Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer (NCT05597527) | Fujian Cancer Hospital | 2022-11-01 |
| Treatment of Epidermoid Cysts (NCT05597995) | Goldman, Butterwick, Fitzpatrick and Groff | 2022-11-01 |
| Addition of Everolimus to Standard of Care in Carcinoma Gallbladder (NCT05833815) | Banaras Hindu University | 2022-11-01 |
| Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC (NCT05575635) | Henan Provincial People's Hospital | 2022-11-01 |
| Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies (NCT05583175) | Xianmin Song, MD | 2022-11-01 |
| Metformin in Patients With Ulcerative Colitis Treated With Mesalamine (NCT05553704) | Tanta University | 2022-11-01 |
| Selinexor in Combination With R-CHOP Followed by Selinexor Maintenance for Untreated EBV-positive DLBCL Patients (NCT05577364) | Sun Yat-sen University | 2022-11-01 |
| Clinical Study of Azacitidine Combined With Ruxolitinib in the Treatment of Higher-risk MDS/MPN (NCT05817955) | The First Affiliated Hospital with Nanjing Medical University | 2022-11-01 |
| A Study of Distal Jejunal-release Dextrose in Obese Participants (NCT05385978) | Aphaia Pharma US LLC | 2022-11-01 |
| A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects (NCT05602129) | Haisco Pharmaceutical Group Co., Ltd. | 2022-11-01 |
| The Effect of Cilostazol on Rheumatoid Arthritis Patients (NCT05671497) | Ain Shams University | 2022-11-01 |
| Neoadjuvant Inituomab, Pyrrolidone and Nab-paclitaxel for HER2+Breast Cancer (NCT05444998) | Xijing Hospital | 2022-11-01 |
| Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower) (NCT05577923) | Fudan University | 2022-11-01 |
| Effect of Topical Agents With Various Antioxidant Containts on Photodamage Skin Induced (NCT06170346) | Universitas Padjadjaran | 2022-11-01 |
| Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies (NCT05537766) | Kite, A Gilead Company | 2022-11-01 |
| A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma (NCT05572463) | Innovent Biologics (Suzhou) Co. Ltd. | 2022-11-01 |
| A Dyadic Approach to Perinatal Depression in Primary Care: Maternal Infant and Dyadic Care (NCT04998721) | University of Washington | 2022-11-01 |
| A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA (NCT05601232) | Stella Pharma Corporation | 2022-11-01 |
| Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer (NCT05451290) | First Affiliated Hospital of Zhejiang University | 2022-11-01 |
| The Covid-19 Outpatient Symptom Montelukast Oximetry Trial (NCT04389411) | McGill University | 2022-11-01 |
| Treatment of Frostbite Sequelae With Botulinum Toxin A (NCT06460194) | University Hospital of North Norway | 2022-11-01 |
| Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer (NCT04947189) | St Vincent's Hospital, Sydney | 2022-11-01 |
| Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma (NCT05180097) | Canadian Cancer Trials Group | 2022-11-01 |
| A Real-World Study of Pyrrolitinib Maleate Tablets for HER-2-Positive Early or Locally Advanced Breast Cancer After Adjuvant Trastuzumab Therapy (NCT06470347) | Zunyi Medical College | 2022-11-01 |
| Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells (NCT05520112) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2022-11-01 |
| Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma (NCT06122493) | Ruijin Hospital | 2022-11-01 |
| A Study of ZEN003694 in People With Squamous Cell Lung Cancer (NCT05607108) | Memorial Sloan Kettering Cancer Center | 2022-11-01 |
| Vitamin E Efficacy in HI/HA (NCT04984798) | Children's Hospital of Philadelphia | 2022-11-01 |
| Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders (NCT05403138) | Tianjin Medical University General Hospital | 2022-11-01 |
| Effects of CB1 Antagonist/Reverse Agonist Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury (NCT05622994) | Hospital Nacional de Parapléjicos de Toledo | 2022-11-01 |
| Vitamin D and Calcium Supplementation in Breast Cancer (NCT05523609) | Tanta University | 2022-11-01 |
| Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma (NCT05602415) | Ruijin Hospital | 2022-11-01 |
| DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation (NCT04616729) | Universitair Ziekenhuis Brussel | 2022-11-01 |
| Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles (NCT05520125) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2022-11-01 |
| Preventive Effect of Acetyl-L-carnitine on Oxaliplatin-induced Peripheral Neuropathy (NCT05601479) | Nanfang Hospital, Southern Medical University | 2022-11-01 |
| Adjunctive Everolimus Treatment of Refractory Epilepsy (NCT05613166) | National Institute on Drug Dependence, China | 2022-11-01 |
| Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances (NCT05092451) | M.D. Anderson Cancer Center | 2022-11-01 |
| Efficacy and Safety of Using Granules Dendrobii for the Treatment of Chronic Atrophic Gastritis (NCT05209633) | Chinese University of Hong Kong | 2022-11-01 |
| A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors (NCT05585320) | Immuneering Corporation | 2022-10-31 |
| Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors (NCT05909436) | Guangzhou Gloria Biosciences Co., Ltd. | 2022-10-31 |
| Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP (NCT05308472) | Disc Medicine, Inc | 2022-10-31 |
| Pembrolizumab Plus Radiotherapy for Advanced Renal Cancer (NCT05567588) | Nanfang Hospital, Southern Medical University | 2022-10-31 |
| A Dose-escalation and Dose-expansion Phase I/Phase II Clinical Study of Dositinib Mesylate Tablets (90-1408) in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer With Positive EGFR Mutation (NCT07231068) | Henan Genuine Biotech Co., Ltd. | 2022-10-31 |
| Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study) (NCT05516498) | AstraZeneca | 2022-10-31 |
| First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria (NCT05781399) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-10-31 |
| JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM) (NCT06595186) | JenKem Technology Co., Ltd. | 2022-10-31 |
| Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy (NCT06826092) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2022-10-31 |
| Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma (NCT04933539) | National Cancer Institute (NCI) | 2022-10-31 |
| Treatment of Hemorrhagic Fever With Ribavirin (NCT04283513) | U.S. Army Medical Research and Development Command | 2022-10-31 |
| A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML (NCT05133882) | Sunshine Lake Pharma Co., Ltd. | 2022-10-31 |
| A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A (NCT05567783) | Vir Biotechnology, Inc. | 2022-10-30 |
| Envafolimab, Lenvatinib Combined With TACE in the Treatment of Unresectable Locally Advanced Hepatocellular Carcinoma (NCT05582109) | Tianjin Medical University Cancer Institute and Hospital | 2022-10-30 |
| A Study of CM313 Injection in Subjects With Systemic Lupus Erythematosus (NCT05465707) | Keymed Biosciences Co.Ltd | 2022-10-30 |
| Ibogaine in the Treatment of Alcoholism: an Open-label Escalating-dose Trial (NCT03380728) | University of Sao Paulo | 2022-10-30 |
| Photobiomodulation in Post Menopause Genitourinary Syndrome (NCT05557799) | University of Nove de Julho | 2022-10-30 |
| Ayahuasca and Esketamine for Major Depression (NCT07212946) | University of Sao Paulo | 2022-10-30 |
| Zanubrutinib in Maintenance Therapy of DLBCL Patients With Initial Remission (NCT05596097) | LanZhou University | 2022-10-30 |
| [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2 (NCT05579184) | FutureChem | 2022-10-30 |
| Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0) (NCT05603013) | Second Affiliated Hospital of Soochow University | 2022-10-30 |
| Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF (NCT05284617) | Rivus Pharmaceuticals, Inc. | 2022-10-30 |
| Efficacy of 0.38% and 0.18% Sodium Hyaluronate Ocular Lubricants for Dry Eye in Adult Gazan Participants (NCT06851364) | International Islamic University Malaysia | 2022-10-30 |
| Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis (NCT05455112) | Archivel Farma S.L. | 2022-10-29 |
| PD-1 Antibody in Addition to BACE in Patients With NSCLC: A Randomised Controlled Trial (NCT05605613) | Xuhua Duan | 2022-10-29 |
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza (NCT05596734) | BioNTech SE | 2022-10-28 |
| Niraparib as First Line Therapy With Metastatic Homologous Repair-deficient Pancreatic Cancer (NCT05442749) | Centre Leon Berard | 2022-10-28 |
| A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone (NCT05607901) | Tanta University | 2022-10-28 |
| Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma (NCT05665023) | Yonsei University | 2022-10-28 |
| Paresthesia-free Peripheral Nerve Field Stimulation for Trigeminal Neuralgia (FreeST Trial) (NCT05615714) | University Health Network, Toronto | 2022-10-28 |
| Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients (NCT05595109) | Tanta University | 2022-10-28 |
| The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot Study (NCT05508633) | Shanghai Changzheng Hospital | 2022-10-28 |
| International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response (NCT05593770) | NEAT ID Foundation | 2022-10-27 |
| AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS (NCT05195645) | Assistance Publique - Hôpitaux de Paris | 2022-10-27 |
| Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity (NCT05579977) | Pfizer | 2022-10-27 |
| ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression (NCT05434156) | Eleusis Therapeutics | 2022-10-27 |
| SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN) (NCT05435742) | Sonnet BioTherapeutics | 2022-10-27 |
| TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT05563480) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-10-27 |
| Effect of PP-01 on Cannabis Withdrawal Syndrome (NCT05494437) | PleoPharma, Inc. | 2022-10-27 |
| Impact of Flavors on Nicotine Perception and Self-Administration Via E-cigarettes (NCT04038515) | Yale University | 2022-10-27 |
| Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2) (NCT05522231) | Hutchmed | 2022-10-27 |
| Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC) (NCT05784142) | Jiangsu Cancer Institute & Hospital | 2022-10-27 |
| Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder (NCT05600114) | EmpowerPharm Inc. | 2022-10-27 |
| Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for de Novo Acute Myeloid Leukemia (NCT05906914) | First Affiliated Hospital of Zhejiang University | 2022-10-26 |
| The Efficacy and Safety of an Amino Acid Supplement in Adults (NCT05599282) | ZandA Technologies, llc | 2022-10-26 |
| A Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLC (NCT05519865) | Chipscreen Biosciences, Ltd. | 2022-10-26 |
| A Study in Participants With Non-cirrhotic NASH With Fibrosis (NCT05638737) | AstraZeneca | 2022-10-26 |
| A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria (NCT05528861) | Allakos Inc. | 2022-10-26 |
| Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis (NCT05451771) | Columbia University | 2022-10-26 |
| BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors (NCT05120271) | Sotio Biotech Inc. | 2022-10-26 |
| A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers (NCT05549609) | Xintela AB | 2022-10-26 |
| A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma (NCT05417932) | SCG Cell Therapy Pte. Ltd. | 2022-10-26 |
| Clinical Trial to Evaluate Safety and Efficiency of Mesenchymal Stem Cell in Patients With Hidradenitis Suppurativa (NCT05934825) | Andalusian Network for Design and Translation of Advanced Therapies | 2022-10-26 |